Detection of Thrombomodulin Level in Patients with Hepatocellular Carcinoma

周俭,汤钊猷,樊嘉,吴志全,李晓明,叶胜龙

DOI: https://doi.org/10.3969/j.issn.1672-8467.2003.01.003

2003-01-01

Abstract:Purpose To detect the thrombomodulin(TM) level in patients with hepatocellular carcinoma(HCC) and explore its relation to the clinicopathological futures of HCC. Methods 45 cases of patients with HCC,6 cases of patients with benign liver occupying lesions(BLOL) and 10 adult control were enrolled in this study.Pre-and-postoperative plasma TM level of patients with HCC and (BLOL) was measured by enzyme linked immunosorbent assay,and the expression of TM in human HCC tissues was determined by immunohistochemistry assay. Results The preoperative plasma TM level of patients with HCC(10.2±5.7)ng/mL was significantly higher than that of those patients with BLOL(6.1±2.2)ng/mL and that of normal control(5.7±1.0)ng/mL,respectively(P0.05).The postoperative TM level of 40 patients with HCC whose tumors had been removed decreased significantly than the preoperative TM level[(10.8± 5.3) ng/mL versus (7.6±4.2)ng/mL,P0.05],whereas there was no significant difference between the preoperative and postoperative TM level of 6 patients with BLOL(P0.05).The preoperative plasma TM level of patients with single HCC(11.5±5.9)ng/mL or no portal vein tumor thrombus(PVTT)(11.4±5.6)ng/mL was significantly higher than that of those patients with multiple HCC(8.1±4.6)ng/mL or PVTT(6.9±4.5)ng/mL,respectively(P0.05).The preoperative plasma TM level of the patients with HCC tissue that stained positive for TM was significantly higher than those with tissue that stained negative for TM(P0.05).The postoperative plasma TM level showed no difference between the patients with HCC tissue stained positive and negative for TM(P0.05).There was also no significant difference between the plasma TM level and other clinicopathological futures. Conclusions Plasma TM increases in patients with HCC and correlates the formation of PVTT.